Variant report
Variant | esv2760922 |
---|---|
Chromosome Location | chr5:119008055-119019976 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:119011346-119011639 | HepG2 | liver: | n/a | chr5:119011499-119011510 |
2 | CEBPB | chr5:119011424-119011579 | A549 | lung: | n/a | chr5:119011499-119011510 |
3 | CEBPB | chr5:119011375-119011613 | IMR90 | lung: | n/a | chr5:119011499-119011510 |
4 | CTCF | chr5:119010165-119010221 | GM13976 | blood: | n/a | n/a |
5 | MAFF | chr5:119014110-119014262 | HepG2 | liver: | n/a | n/a |
6 | MAFF | chr5:119018108-119018428 | HepG2 | liver: | n/a | chr5:119018254-119018272 |
7 | MAFK | chr5:119018131-119018400 | HepG2 | liver: | n/a | chr5:119018258-119018272 |
8 | MAFK | chr5:119011481-119011643 | HepG2 | liver: | n/a | n/a |
9 | MAFK | chr5:119018085-119018437 | HepG2 | liver: | n/a | chr5:119018258-119018272 |
10 | MAFK | chr5:119014092-119014275 | HepG2 | liver: | n/a | n/a |
11 | MAFK | chr5:119011472-119011726 | HepG2 | liver: | n/a | n/a |
12 | MYC | chr5:119019381-119019404 | GM12878 | blood: | n/a | n/a |
13 | MYC | chr5:119017066-119017126 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr5:119016426-119016439 | Gliobla | brain: | n/a | n/a |
15 | POLR2A | chr5:119016548-119016577 | Gliobla | brain: | n/a | n/a |
16 | POLR2A | chr5:119009506-119009592 | GM12878 | blood: | n/a | n/a |
17 | POLR2A | chr5:119017032-119017200 | A549 | lung: | n/a | n/a |
18 | POLR2A | chr5:119015935-119015954 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr5:119016914-119017146 | MCF-7 | breast: | n/a | n/a |
20 | POLR2A | chr5:119016590-119016659 | Gliobla | brain: | n/a | n/a |
21 | POLR2A | chr5:119015964-119015974 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr5:119016749-119016765 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr5:119016704-119016705 | MCF-7 | breast: | n/a | n/a |
24 | SPI1 | chr5:119017422-119017721 | HL-60 | blood: | n/a | chr5:119017598-119017607 chr5:119017513-119017526 chr5:119017516-119017523 chr5:119017514-119017527 |
25 | TCF12 | chr5:119014369-119014658 | H1-hESC | embryonic stem cell: | n/a | chr5:119014501-119014508 |
26 | TCF12 | chr5:119014368-119014634 | H1-hESC | embryonic stem cell: | n/a | chr5:119014501-119014508 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234259 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115011643 | chr5:119011348-119011349 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs73249894 | chr5:119011368-119011369 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs578156984 | chr5:119011398-119011399 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs540765132 | chr5:119011500-119011501 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs180813488 | chr5:119011517-119011518 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs529148853 | chr5:119011522-119011523 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs330206 | chr5:119011525-119011526 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs577290796 | chr5:119011564-119011565 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs142569627 | chr5:119011582-119011583 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs187594913 | chr5:119011594-119011595 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs144924230 | chr5:119011616-119011617 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs551106086 | chr5:119011617-119011618 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs571254770 | chr5:119011645-119011646 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs552017446 | chr5:119014121-119014122 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs78707822 | chr5:119014132-119014133 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs527862930 | chr5:119014134-119014135 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs138658309 | chr5:119014163-119014164 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs567853418 | chr5:119014180-119014181 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs192330760 | chr5:119014216-119014217 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs549858639 | chr5:119014250-119014251 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs184336913 | chr5:119014255-119014256 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs538726085 | chr5:119014270-119014271 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs543410806 | chr5:119014385-119014386 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs141347072 | chr5:119014435-119014436 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs115034015 | chr5:119014441-119014442 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs563110915 | chr5:119014449-119014450 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs570087415 | chr5:119014454-119014455 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs7735037 | chr5:119014459-119014460 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs113715108 | chr5:119014468-119014469 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs7717177 | chr5:119014471-119014472 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs527926671 | chr5:119014484-119014485 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs77397809 | chr5:119014502-119014503 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs369472025 | chr5:119014509-119014510 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs74646998 | chr5:119014522-119014523 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs535930027 | chr5:119014552-119014553 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs550166342 | chr5:119014587-119014588 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs563210965 | chr5:119014638-119014639 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs530810293 | chr5:119014644-119014645 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs569986072 | chr5:119014652-119014653 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs538626386 | chr5:119014653-119014654 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs537245538 | chr5:119015812-119015813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs330204 | chr5:119015813-119015814 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs115943951 | chr5:119015882-119015883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539443211 | chr5:119015898-119015899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552976874 | chr5:119015908-119015909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145057793 | chr5:119015912-119015913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112491303 | chr5:119015918-119015919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77998829 | chr5:119015945-119015946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555420236 | chr5:119015946-119015947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574980360 | chr5:119015954-119015955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:119015800-119016200 | Enhancers | Pancreas | Pancrea |
2 | chr5:119015800-119016400 | Enhancers | Fetal Muscle Trunk | muscle |
3 | chr5:119016200-119016800 | ZNF genes & repeats | Pancreas | Pancrea |
4 | chr5:119016400-119016600 | Weak transcription | Fetal Muscle Trunk | muscle |
5 | chr5:119016600-119017800 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr5:119016800-119017000 | Weak transcription | Pancreas | Pancrea |
7 | chr5:119016800-119017800 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr5:119017000-119017200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr5:119017000-119017200 | Enhancers | Fetal Muscle Trunk | muscle |
10 | chr5:119017000-119017200 | Enhancers | Pancreas | Pancrea |
11 | chr5:119017000-119017800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr5:119017200-119019400 | Weak transcription | Pancreas | Pancrea |
13 | chr5:119017400-119017800 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr5:119018200-119019000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr5:119019400-119019600 | Enhancers | Pancreas | Pancrea |